« Back to Record
Citation APA

Awada, A., Hendlisz, A., Gil, T., Munoz Bermeo, R. A., Bartholomeus, S., de Valeriola, D., van der Auwera, J., Coppieters, S., Moeller, J., & Piccart-Gebhart, M. (2002). Final results of a clinical and pharmacokinetic (PK) phase I study of the Raf kinase inhibitor BAY 43-9006 in refractory solid cancers: A promising anti-tumor agent. European Journal of Cancer. Vol. 38 (p. 52) (2002).


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278703

Awada, A., Hendlisz, A., Gil, T., Munoz Bermeo, R. A., Bartholomeus, S., de Valeriola, D., van der Auwera, J., Coppieters, S., Moeller, J., & Piccart-Gebhart, M. (2002). Final results of a clinical and pharmacokinetic (PK) phase I study of the Raf kinase inhibitor BAY 43-9006 in refractory solid cancers: A promising anti-tumor agent. European Journal of Cancer. Vol. 38 (p. 52) (2002).